Tia Virtual Care
On-demand telemedicine platform connecting patients with healthcare providers
Platform · Cloud SaaSCompany source
Company profile
About Tia
Tia is a modern medical home built specifically for women, reimagining healthcare delivery through an integrated model that combines primary care, gynecology, and mental health services. The company operates both physical clinics and a virtual care platform, enabling seamless access to comprehensive women's health services. Tia's care model emphasizes whole-person health, addressing the interconnected nature of physical and mental wellbeing while providing continuity of care across in-person and digital touchpoints. The platform serves women throughout their healthcare journey, from preventive care and routine checkups to chronic condition management and mental health support. By focusing exclusively on women's health, Tia aims to address the historical gaps in medical research and care delivery that have underserved female patients. The company's approach integrates technology with personalized clinical care, offering features like care coordination, appointment scheduling, and ongoing communication with care teams through their digital platform.
Company description Tia official website
Primary marketTelemedicine & Virtual Care
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Tia?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- chronic condition management
- gynecology
- mental health
- preventive care
- primary care
- women's health
Who it serves
- consumers
- women patients
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsNot currently listed
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
New components in genetic regulation of age-dependent compound leaf architecture in pea.The New phytologist · Aug 14, 2026
KongNet: A multi-headed deep learning model for detection and classification of nuclei in histopathology images.Medical image analysis · Jul 25, 2026
Letter to the Editor regarding "End-of-life education: An explorative study using artificial intelligence simulations in undergraduate nursing".Nursing outlook · Jul 16, 2026
Selection of Novel DNA Aptamers against HPV16 Biomarker, E6: An In Silico Approach.ACS omega · Jul 7, 2026
Impact of phospholipase A2 hydrolysis on triplet-triplet annihilation upconversion liposomes.Journal of materials chemistry. B · Jul 1, 2026
Comprehensive Analysis of Physicochemical Properties, Structure, Bioactive Potential, and Flavor Profiles of Tangerine Pericarp Powder from Different Varieties.ACS omega · Jun 30, 2026
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Tia
Recent articles published on Tia's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
India Rewrites the Rulebook for Stem Cell Therapies and Essential Drug Pricing in Landmark Healthcare Reform
New regulatory framework brings gene and cell therapies under formal oversight while controversial pricing changes could reshape access to essential medicines
Policy & Regulation · Jul 3, 2026
Mayo Clinic Study Reveals How Genetic Testing Is Rewriting Pulmonary Fibrosis Care Protocols
Integration of telomere length analysis and genetic sequencing into routine practice is changing diagnoses and treatment decisions for lung disease patients
Clinical AI · Jul 3, 2026
Lab-Grown Blood Vessels Show Promise in Reversing Heart Disease Damage
Preclinical studies reveal engineered vascular organoids can integrate with damaged heart tissue and restore blood flow, offering a regenerative alternative to traditional bypass surgery.
Clinical AI · Jul 3, 2026
Can Rheumatoid Arthritis Be Stopped Before It Starts? Landmark Trial Shows 60% Prevention Success
A groundbreaking UK study demonstrates that early intervention with an existing drug can prevent the onset of debilitating autoimmune disease in high-risk patients, opening the door for AI-powered predictive screening.
Clinical AI · Jul 3, 2026
How Tomorrow's Weather Could Predict Your Hospital's Mental Health Crisis Load
A decade-long analysis of 15 million NHS contacts reveals that daily weather fluctuations—from temperature swings to rainfall—significantly influence mental health service demand, opening new frontiers for AI-powered healthcare forecasting.
Mental & Behavioral Health · Jul 3, 2026
India Launches Unified Drug Database to Power Next-Generation Healthcare AI
New national registry standardizes pharmaceutical data across the world's most populous nation, creating infrastructure for AI-driven clinical tools and medication safety systems.
Policy & Regulation · Jul 3, 2026
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Telemedicine & Virtual Care
Companies providing AI-enhanced telemedicine platforms, virtual care delivery systems, AI-powered triage, or virtual health assistants that facilitate remote clinical consultations between patients and healthcare providers. Includes integrated telehealth platforms with AI capabilities for scheduling, triage, and follow-up care.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.